Triple

T22457957
Position Surface form Disambiguated ID Type / Status
Subject Swissmedic E555161 entity
Predicate predecessor P97 FINISHED
Object Intercantonal Office for the Control of Medicines
The Intercantonal Office for the Control of Medicines was a Swiss regulatory body responsible for overseeing the safety and quality of medicinal products before its functions were taken over at the federal level.
E1538036 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Intercantonal Office for the Control of Medicines | Statement: [Swissmedic, predecessor, Intercantonal Office for the Control of Medicines]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Intercantonal Office for the Control of Medicines
Context triple: [Swissmedic, predecessor, Intercantonal Office for the Control of Medicines]
  • A. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • B. Federal Service for State Registration of Medicines
    The Federal Service for State Registration of Medicines is a Russian government agency responsible for evaluating, approving, and overseeing the circulation of pharmaceutical drugs within the country.
  • C. Italian Medicines Agency
    The Italian Medicines Agency is Italy’s national regulatory authority responsible for evaluating, authorizing, and monitoring medicines and pharmaceutical products.
  • D. National Agency for Food and Drug Administration and Control
    The National Agency for Food and Drug Administration and Control is Nigeria’s federal regulatory body responsible for overseeing the safety, quality, and standardization of food, drugs, cosmetics, medical devices, and related products.
  • E. Centre for Drug Safety
    The Centre for Drug Safety is a specialized unit within the Norwegian Institute of Public Health that focuses on monitoring, researching, and improving the safe use of medicines.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Intercantonal Office for the Control of Medicines
Triple: [Swissmedic, predecessor, Intercantonal Office for the Control of Medicines]
Generated description
The Intercantonal Office for the Control of Medicines was a Swiss regulatory body responsible for overseeing the safety and quality of medicinal products before its functions were taken over at the federal level.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Intercantonal Office for the Control of Medicines
Target entity description: The Intercantonal Office for the Control of Medicines was a Swiss regulatory body responsible for overseeing the safety and quality of medicinal products before its functions were taken over at the federal level.
  • A. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • B. Federal Service for State Registration of Medicines
    The Federal Service for State Registration of Medicines is a Russian government agency responsible for evaluating, approving, and overseeing the circulation of pharmaceutical drugs within the country.
  • C. Italian Medicines Agency
    The Italian Medicines Agency is Italy’s national regulatory authority responsible for evaluating, authorizing, and monitoring medicines and pharmaceutical products.
  • D. National Agency for Food and Drug Administration and Control
    The National Agency for Food and Drug Administration and Control is Nigeria’s federal regulatory body responsible for overseeing the safety, quality, and standardization of food, drugs, cosmetics, medical devices, and related products.
  • E. Centre for Drug Safety
    The Centre for Drug Safety is a specialized unit within the Norwegian Institute of Public Health that focuses on monitoring, researching, and improving the safe use of medicines.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e11e51fdec8190adfdf9f8a6362221 completed April 16, 2026, 5:37 p.m.
NER Named-entity recognition batch_69f15b7d00208190955a70e2c22d25a4 completed April 29, 2026, 1:14 a.m.
NED1 Entity disambiguation (via context triple) batch_6a0b0c7fc40081909f27eb081ac156f1 completed May 18, 2026, 12:56 p.m.
NEDg Description generation batch_6a0b0ddb116c8190b19f9a01abb737e6 completed May 18, 2026, 1:02 p.m.
NED2 Entity disambiguation (via description) batch_6a0b0e4402e481909210c5feff3fcddf completed May 18, 2026, 1:04 p.m.
Created at: April 16, 2026, 8:48 p.m.